Lite Strategy

Lite Strategy

Clinical-stage pharmaceutical company(NASDAQ: LITS)

Tentang Lite Strategy

Didirikan

2018

Komunitas

Lite Strategy, Inc.(NASDAQ: LITS) is a clinical-stage pharmaceutical company headquartered in San Diego, California, USA, focused on developing innovative therapies that primarily combat drug resistance mechanisms in cancer, aiming to improve patient outcomes in combination with standard treatments.

Detail penggalangan dana

Putaran PendanaanJumlahPenilaian
Date
Investor
Post-IPO
Rp1.64T
--
2025-07-21
--